119 results on '"MANARA, E."'
Search Results
2. Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group
- Author
-
Manara, E, Basso, G, Zampini, M, Buldini, B, Tregnago, C, Rondelli, R, Masetti, R, Bisio, V, Frison, M, Polato, K, Cazzaniga, G, Menna, G, Fagioli, F, Merli, P, Biondi, A, Pession, A, Locatelli, F, and Pigazzi, M
- Published
- 2017
- Full Text
- View/download PDF
3. CREB engages C/EBPδ to initiate leukemogenesis
- Author
-
Tregnago, C, Manara, E, Zampini, M, Bisio, V, Borga, C, Bresolin, S, Aveic, S, Germano, G, Basso, G, and Pigazzi, M
- Published
- 2016
- Full Text
- View/download PDF
4. CDH5, a Possible New Candidate Gene for Genetic Testing of Lymphedema
- Author
-
Michelini, S., Ricci, M., Amato, B., Gentileschi, Stefano, Veselenyiova, D., Kenanoglu, S., Fiorentino, A., Kurti, D., Baglivo, M., Manara, E., Basha, S. H., Priya, S., Krajcovic, J., Dundar, M., Belgrado, J. P., Dautaj, A., Bertelli, M., Gentileschi S. (ORCID:0000-0001-9682-4706), Michelini, S., Ricci, M., Amato, B., Gentileschi, Stefano, Veselenyiova, D., Kenanoglu, S., Fiorentino, A., Kurti, D., Baglivo, M., Manara, E., Basha, S. H., Priya, S., Krajcovic, J., Dundar, M., Belgrado, J. P., Dautaj, A., Bertelli, M., and Gentileschi S. (ORCID:0000-0001-9682-4706)
- Abstract
Background: Expressed by endothelial cells, CDH5 is a cadherin involved in vascular morphogenesis and in the maintenance of vascular integrity and lymphatic function. The main purpose of our study was to identify distinct variants of the CDH5 gene that could be associated with lymphatic malformations and predisposition for lymphedema. Methods and Results: We performed Next Generation Sequencing of the CDH5 gene in 235 Italian patients diagnosed with lymphedema but who tested negative for variants in known lymphedema genes. We detected six different variants in CDH5 five missense and one nonsense. We also tested available family members of the probands. For family members who carried the same variant as the proband, we performed lymphoscintigraphy to detect any lymphatic system abnormalities. Variants were modeled in silico. The results showed that CDH5 variants may contribute to the onset of lymphedema, although further in vitro studies are needed to confirm this hypothesis. Conclusions: Based on our findings, we propose CDH5 as a new gene that could be screened in patients with lymphedema to gather additional evidence.
- Published
- 2022
5. In vitro and clinical studies on the efficacy of α-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection
- Author
-
Paolacci, S., Ergoren, M. C., De Forni, D., Manara, E., Poddesu, B., Cugia, G., Dhuli, K., Camilleri, G., Tuncel, G., Kaya Suer, H., Sultanoglu, N., Sayan, M., Dundar, M., Beccari, T., Ceccarini, M. R., Gunsel, I. S., Dautaj, A., Sanlidag, T., Connelly, S. T., Tartaglia, G. M., and Bertelli, M.
- Subjects
Adult ,Male ,alpha-Cyclodextrins ,Health Personnel ,ACE2 ,Gene Expression ,Cell Line ,Young Adult ,Anti-Infective Agents ,Chlorocebus aethiops ,Animals ,Humans ,Hydroxytyrosol ,Viral ,alpha-cyclodextrin ,Administration, Intranasal ,Aged ,Reverse Transcriptase Polymerase Chain Reaction ,SARS-CoV-2 ,COVID-19 ,Middle Aged ,Phenylethyl Alcohol ,Virus Internalization ,Intranasal ,Administration ,RNA ,RNA, Viral ,Female - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the current pandemic of coronavirus disease 2019 (COVID-19). This virus attacks cells of the airway epithelium by binding transmembrane angiotensin-converting enzyme 2 (ACE2). Hydroxytyrosol has anti-viral properties. Alpha-cyclodextrin can deplete sphingolipids and phospholipids from cell membranes. The aim of the present experimental study was to evaluate the efficacy of α-cyclodextrin and hydroxytyrosol in improving defenses against SARS-CoV-2 infection in in vitro cell models and humans.For in vitro experiments on Vero E6 cells, RNA for RT-qPCR analysis was extracted from Caco2 and human fibroblast cell lines. For study in humans, the treatment group consisted of 149 healthy volunteers in Northern Cyprus, considered at higher risk of SARS-CoV-2 infection than the general population. The volunteers used nasal spray containing α-cyclodextrin and hydroxytyrosol for 4 weeks. The control group consisted of 76 healthy volunteers who did not use the spray.RT-qPCR experiments on targeted genes involved in endocytosis showed a reduction in gene expression, whereas cytotoxicity and cytoprotective tests showed that the compounds exerted a protective effect against SARS-CoV-2 infection at non-cytotoxic concentrations. None of the volunteers became positive to SARS-CoV-2 RT-qPCR assay during the 30 days of treatment.Treatment with α-cyclodextrin and hydroxytyrosol nasal spray improved defenses against SARS-CoV-2 infection and reduced synthesis of viral particles.
- Published
- 2021
6. Models of Training Mediators for Education: Experience of Siberia and Kazakhstan
- Author
-
Olga G. Smolyaninova, Vera V. Korshunova, and Manara E. Adamova
- Subjects
Medical education ,Anthropology ,05 social sciences ,Conflict resolution ,050301 education ,050109 social psychology ,0501 psychology and cognitive sciences ,Psychology ,0503 education ,Training (civil) - Abstract
The article describes various models of training mediators for the education system in the Russian Federation and the Republic of Kazakhstan. A comparative analysis of the mediation services development in Siberia and Kazakhstan for the possibilities and prospects of cooperation and interaction is carried out. The article presents specific features of the model for training intercultural mediators for resolving interethnic conflicts in the Krasnoyarsk Krai. This model meets the needs of multinational Siberian society and is aimed at solving regional problems in the education system. A peculiar characteristic of the model for the Krasnoyarsk Krai is its multi-level nature, openness and continuity of preparation, with the inclusion of formal and non-formal education elements. Interdisciplinary nature of interaction of the network partners involved in the training and retraining of mediators for the education system gives an opportunity to use the potential and resources of professional mediators and trainers of Siberia (Kemerovo, Irkutsk), Federal Institute of Mediation, Moscow, and National Academy of Education named after Y. Altynsarin (Kazakhstan). The model for the intercultural mediators training developed at the School of Education, Psychology and Sociology has been tested for two years as a part of its implementation in the Master programme of the School of Education, Psychology and Sociology within the frames of the educational programme “Mediation in Education”, advanced training courses, three International Youth Summer Schools “Multicultural Mediation in Education”, expert seminars, intensive schools “Mediation is the Profession of the 21st Century”, and a competition for high school students of the Krasnoyarsk Krai “Mediation Is The Profession Of The Future”
- Published
- 2019
7. In vitro and clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection
- Author
-
Poddesu, B., Cugia, G., Dhuli, K., Camilleri, G., Tuncel, G., Suer, H. Kaya, DÜNDAR, MUNİS, Sultanoglu, N., Sayan, M., Ergoren, M. C., Beccari, T., Ceccarini, M. R., Gunsel, I. S., Dautaj, A., Sanlidag, T., Connelly, S. T., Bertelli, M., Paolacci, S., De Forni, D., Tartaglia, G. M., and Manara, E.
- Subjects
viruses ,virus diseases ,lipids (amino acids, peptides, and proteins) - Abstract
OBJECTIVE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the current pandemic of coronavirus disease 2019 (COVID-19). This virus attacks cells of the airway epithelium by binding transmembrane angiotensin-converting enzyme 2 (ACE2). Hydroxytyrosol has anti-viral properties. Alpha-cyclodextrin can deplete sphingolipids and phospholipids from cell membranes. The aim of the present experimental study was to evaluate the efficacy of alpha-cyclodextrin and hydroxytyrosol in improving defenses against SARS-CoV-2 infection in in vitro cell models and humans.
- Published
- 2021
8. Study of the effects of Lemna minor extracts on human immune cell populations
- Author
-
Catelani Cardoso, C., Miraldi, E., Ceccarini, M. R., Naureen, Z., Baini, G., Manara, E., Anpilogov, K., Camilleri, G., Dhuli, K., Paolacci, S., Ria, Francesco, Di Sante, Gabriele, Camponeschi, C., Tredicine, Maria, Zanlari, A., Chiurazzi, Pietro, Beccari, T., Bertelli, M., Ria F. (ORCID:0000-0002-8444-0307), Di Sante G. (ORCID:0000-0001-6608-3388), Tredicine M., Chiurazzi P. (ORCID:0000-0001-5104-1521), Catelani Cardoso, C., Miraldi, E., Ceccarini, M. R., Naureen, Z., Baini, G., Manara, E., Anpilogov, K., Camilleri, G., Dhuli, K., Paolacci, S., Ria, Francesco, Di Sante, Gabriele, Camponeschi, C., Tredicine, Maria, Zanlari, A., Chiurazzi, Pietro, Beccari, T., Bertelli, M., Ria F. (ORCID:0000-0002-8444-0307), Di Sante G. (ORCID:0000-0001-6608-3388), Tredicine M., and Chiurazzi P. (ORCID:0000-0001-5104-1521)
- Abstract
OBJECTIVE: Lemna minor is a plant with a huge repertoire of secondary metabolites. The literature indicates that extracts of Lemna minor have antioxidant, antiradical, immunomodulatory and anti-inflammatory properties. The objective of the present study was to find a suitable technique to extract active compounds from this plant and verify whether these extracts have immunomodulatory activity. MATERIALS AND METHODS: We grew L. minor on a standard medium with Gamborg B5 and vitamins. We extracted compounds from the plant by maceration and decoction. The phytochemical profile of the extracts was characterized by chromatography, spectrophotometry, and spectroscopy. The extracts were tested on cultures of mononuclear cells from four human subjects. These cells were pulsed with carboxyfluorescein succinimidyl ester, grown in triplicate in standard culture medium without (control) and with increasing concentrations of Lemna extracts. Flow cytometry was used to evaluate cell death and proliferation of the total mononuclear cell population and of CD4+, CD8+, B cell and monocyte populations. RESULTS: The Lemna extracts were not cytotoxic and did not cause cell necrosis or apoptosis in immune cells. At low concentrations, they induced very limited proliferation of CD4+ cells within 48 hours. At high concentrations, they induced proliferation of CD8+ cells and B lymphocytes within 48 hours. CONCLUSIONS: Unfortunately, we failed to confirm any immunomodulatory activity of Lemna extracts. Growth and death rates of human immune cells were not significantly affected by adding Lemna extracts to the culture medium.
- Published
- 2021
9. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME)
- Author
-
Lupo, Giuseppe Francesco Damiano, Rocchetti, Gabriele, Lucini, Luigi, Lorusso, L., Manara, E., Bertelli, M., Puglisi, Edoardo, Capelli, E., Lupo G. F. D. (ORCID:0000-0002-1894-5075), Rocchetti G. (ORCID:0000-0003-3488-4513), Lucini L. (ORCID:0000-0002-5133-9464), Puglisi E. (ORCID:0000-0001-5051-0971), Lupo, Giuseppe Francesco Damiano, Rocchetti, Gabriele, Lucini, Luigi, Lorusso, L., Manara, E., Bertelli, M., Puglisi, Edoardo, Capelli, E., Lupo G. F. D. (ORCID:0000-0002-1894-5075), Rocchetti G. (ORCID:0000-0003-3488-4513), Lucini L. (ORCID:0000-0002-5133-9464), and Puglisi E. (ORCID:0000-0001-5051-0971)
- Abstract
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a severe multisystemic disease characterized by immunological abnormalities and dysfunction of energy metabolism. Recent evidences suggest strong correlations between dysbiosis and pathological condition. The present research explored the composition of the intestinal and oral microbiota in CFS/ME patients as compared to healthy controls. The fecal metabolomic profile of a subgroup of CFS/ME patients was also compared with the one of healthy controls. The fecal and salivary bacterial composition in CFS/ME patients was investigated by Illumina sequencing of 16S rRNA gene amplicons. The metabolomic analysis was performed by an UHPLC-MS. The fecal microbiota of CFS/ME patients showed a reduction of Lachnospiraceae, particularly Anaerostipes, and an increased abundance of genera Bacteroides and Phascolarctobacterium compared to the non-CFS/ME groups. The oral microbiota of CFS/ME patients showed an increase of Rothia dentocariosa. The fecal metabolomic profile of CFS/ME patients revealed high levels of glutamic acid and argininosuccinic acid, together with a decrease of alpha-tocopherol. Our results reveal microbial signatures of dysbiosis in the intestinal microbiota of CFS/ME patients. Further studies are needed to better understand if the microbial composition changes are cause or consequence of the onset of CFS/ME and if they are related to any of the several secondary symptoms.
- Published
- 2021
10. Identification of unsolved rare genetic cases of North Cyprus
- Author
-
Mahmut Cerkez Ergoren, Manara, E., Paolacci, S., Tuncel, G., Temel, S. G., Mocan, G., Dundar, M., and Bertelli, M.
- Published
- 2020
11. Foxc2 disease mutations identified in lymphedema distichiasis patients impair transcriptional activity and cell proliferation
- Author
-
Tavian, Daniela, Missaglia, Sara, Michelini, S, Maltese, Pe, Manara, E, Mordente, Alvaro, Bertelli, M., Tavian D (ORCID:0000-0003-3333-0068), Missaglia S (ORCID:0000-0001-6551-6698), Mordente A (ORCID:0000-0003-3260-9796), Tavian, Daniela, Missaglia, Sara, Michelini, S, Maltese, Pe, Manara, E, Mordente, Alvaro, Bertelli, M., Tavian D (ORCID:0000-0003-3333-0068), Missaglia S (ORCID:0000-0001-6551-6698), and Mordente A (ORCID:0000-0003-3260-9796)
- Abstract
FOXC2 is a member of the human forkhead-box gene family and encodes a regulatory transcription factor. Mutations in FOXC2 have been associated with lymphedema distichiasis (LD), an autosomal dominant disorder that primarily affects the limbs. Most patients also show extra eyelashes, a condition known as distichiasis. We previously reported genetic and clinical findings in six unrelated families with LD. Half the patients showed missense mutations, two carried frameshift mutations and a stop mutation was identified in a last patient. Here we analyzed the subcellular localization and transactivation activity of the mutant proteins, showing that all but one (p.Y109*) localized to the nucleus. A significant reduction of transactivation activity was observed in four mutants (p.L80F, p.H199Pfs*264, p.I213Tfs*18, p.Y109*) compared with wild type FOXC2 protein, while only a partial loss of function was associated with p.V228M. The mutant p.I213V showed a very slight increase of transactivation activity. Finally, immunofluorescence analysis revealed that some mutants were sequestered into nuclear aggregates and caused a reduction of cell viability. This study offers new insights into the effect of FOXC2 mutations on protein function and shows the involvement of aberrant aggregation of FOXC2 proteins in cell death.
- Published
- 2020
12. Taste, olfactory and texture related genes and food choices: implications on health status
- Author
-
Precone, V., Beccari, T., Stuppia, L., Baglivo, M., Paolacci, S., Manara, E., Miggiano, G. A. D., Falsini, B., Trifiro, A., Zanlari, A., Herbst, K. L., Unfer, V., and Bertelli, M.
- Subjects
Texture sensations ,Eating ,Food Preferences ,Health Status ,Taste ,Obesity ,Olfactory receptors ,Taste receptors ,Humans ,Taste Perception ,Receptors, Odorant ,Receptors, G-Protein-Coupled - Abstract
The food choices are due to a mixture of sensory signals including gustatory, olfactory, and texture sensations. The aim of this quality review was to update data about studies concerning genetics of taste, olfactory and texture receptors and their influence on the health status in humans.An electronic search was conducted in MEDLINE, Pubmed database and Scopus, for articles published in English until December 2018. Two independent researches selected the studies and extracted the data.The review confirms the importance of inter-individual variations in taste, olfactory and texture related genes on food choices and their implications in the susceptibility to nutrition-related conditions such as obesity, dental caries, diabetes, cardiovascular disease, hypertension, hyperlipidemia and cancer.The knowledge of variants in taste, olfactory and texture related genes can contribute to the prevention of diseases related to unhealthy nutrition. Further studies would be useful to identify other variants in the genes involved in these systems.
- Published
- 2019
13. PipeMAGI: an integrated and validated workflow for analysis of NGS data for clinical diagnostics
- Author
-
Marceddu, G, Dallavilla, T, Guerri, G, Manara, E, Chiurazzi, Pietro, Bertelli, M, Chiurazzi, P (ORCID:0000-0001-5104-1521), Marceddu, G, Dallavilla, T, Guerri, G, Manara, E, Chiurazzi, Pietro, Bertelli, M, and Chiurazzi, P (ORCID:0000-0001-5104-1521)
- Abstract
OBJECTIVE: We describe how to set up a custom workflow for the analysis of next generation sequencing (NGS) data suitable for the diagnosis of genetic disorders and that meets the strictest standards of quality and accuracy. Our method goes from DNA extraction to data analysis with a computational in-house pipeline. The system was extensively validated using three publicly available Coriell samples, estimating accuracy, sensitivity and specificity. Multiple runs were also made to assess repeatability and reproducibility.MATERIALS AND METHODS: Three different Coriell samples were analyzed in a single run to perform coverage, sensitivity, specificity, accuracy, reproducibility and repeatability analysis. The three samples were analyzed with a custom-made oligonucleotide probe library using Nextera Rapid Capture enrichment technique and subsequently quantified using the Qubit method. Sample quality was verified using a 4200 TapeStation and sequenced on a MiSeq personal sequencer. Analysis of NGS data was then performed with a custom pipeline.RESULTS: The workflow enabled an accurate and precise analysis of NGS data that meets all the requirements of quality and accuracy required by international standards such as ISO15189 and the Association of Molecular Pathology.CONCLUSIONS: The proposed analysis/validation workflow has high assay accuracy, precision and robustness and can, therefore, be used for clinical diagnostic applications.
- Published
- 2019
14. Mutation profile of BBS genes in patients with Bardet-Biedl syndrome: An Italian study
- Author
-
Manara, E., Paolacci, S., D'Esposito, F., Abeshi, A., Ziccardi, L., Falsini, Benedetto, Colombo, L., Iarossi, G., Pilotta, A., Boccone, L., Guerri, Giulia, Monica, M., Marta, B., Maltese, P. E., Buzzonetti, Luca, Rossetti, Lodovico, Bertelli, M., Falsini B. (ORCID:0000-0002-3569-4968), Guerri G., Buzzonetti L. (ORCID:0000-0002-3200-3260), Rossetti L., Manara, E., Paolacci, S., D'Esposito, F., Abeshi, A., Ziccardi, L., Falsini, Benedetto, Colombo, L., Iarossi, G., Pilotta, A., Boccone, L., Guerri, Giulia, Monica, M., Marta, B., Maltese, P. E., Buzzonetti, Luca, Rossetti, Lodovico, Bertelli, M., Falsini B. (ORCID:0000-0002-3569-4968), Guerri G., Buzzonetti L. (ORCID:0000-0002-3200-3260), and Rossetti L.
- Abstract
Background: Bardet-Biedl syndrome (BBS) is a rare inherited multisystemic disorder with autosomal recessive or complex digenic triallelic inheritance. There is currently no treatment for BBS, but some morbidities can be managed. Accurate molecular diagnosis is often crucial for the definition of appropriate patient management and for the development of a potential personalized therapy. Methods: We developed a next-generation-sequencing (NGS) protocol for the screening of the 18 most frequently mutated genes to define the genotype and clarify the mutation spectrum of a cohort of 20 BBS Italian patients. Results: We defined the causative variants in 60% of patients; four of those are novel. 33% of patients also harboured variants in additional gene/s, suggesting possible oligogenic inheritance. To explore the function of different genes, we looked for correlations between genotype and phenotype in our cohort. Hypogonadism was more frequently detected in patients with variants in BBSome proteins, while renal abnormalities in patients with variations in BBSome chaperonin genes. Conclusions: NGS is a powerful tool that can help understanding BBS patients' phenotype through the identification of mutations that could explain differences in phenotype severity and could provide insights for the development of targeted therapy. Furthermore, our results support the existence of additional BBS loci yet to be identified.
- Published
- 2019
15. Quality assurance of genetic laboratories and the EBTNA practice certification
- Author
-
Manara, E., primary, Precone, V., additional, Dundar, M., additional, Beccari, T., additional, Cecchin, S., additional, Marceddu, G., additional, and Bertelli, M., additional
- Published
- 2019
- Full Text
- View/download PDF
16. PIPE-MAGI, Bioinformatic system for the analysis of NGS data
- Author
-
Bertelli, M., primary, Marceddu, G., additional, Dallavilla, T., additional, Guerri, G., additional, Maltese, P.E., additional, Manara, E., additional, and Paolacci, S., additional
- Published
- 2019
- Full Text
- View/download PDF
17. Next generation sequencing analysis of patients with Mendelian obesity
- Author
-
Paolacci, S., primary, Maltese, P.E., additional, Manara, E., additional, Iarossi, G., additional, Ziccardi, L., additional, Colombo, L., additional, Falsini, B., additional, and Bertelli, M., additional
- Published
- 2019
- Full Text
- View/download PDF
18. Application of high-throughput DNA sequencing to score population-specific variants for rare disorders
- Author
-
Ergoren, M.C., primary, Manara, E., additional, Paolacci, S., additional, Temel, S.G., additional, Mocan, G., additional, Dundar, M., additional, and Bertelli, M., additional
- Published
- 2019
- Full Text
- View/download PDF
19. Target and whole exome sequencing in families with lymphedema and lipedema
- Author
-
Maltese, P.E., primary, Manara, E., additional, Paolacci, S., additional, Marceddu, G., additional, Michelini, S., additional, and Bertelli, M., additional
- Published
- 2019
- Full Text
- View/download PDF
20. Models of Training Mediators for Education: Experience of Siberia and Kazakhstan
- Author
-
Smolyaninova, Olga G., primary, Korshunova, Vera V., additional, and Adamova, Manara E., additional
- Published
- 2019
- Full Text
- View/download PDF
21. Research Article Glu298Asp polymorphism in the NOS3 gene is not associated with susceptibility to chronic heart failure in a Russian population
- Author
-
Goppe, E.S., primary, Maltese, P.E., additional, Chernova, A., additional, Nikulina, S.Y., additional, Semenchukov, A., additional, Matveeva, A., additional, Manara, E., additional, and Bertelli, M., additional
- Published
- 2019
- Full Text
- View/download PDF
22. Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML
- Author
-
Zampini, M., Tregnago, C., Bisio, V., Simula, L., Borella, G., Manara, E., Zanon, C., Zonta, F., Serafin, V., Accordi, B., Campello, S., Buldini, B., Pession, A., Locatelli, Franco, Basso, G., Pigazzi, M., Locatelli F. (ORCID:0000-0002-7976-3654), Zampini, M., Tregnago, C., Bisio, V., Simula, L., Borella, G., Manara, E., Zanon, C., Zonta, F., Serafin, V., Accordi, B., Campello, S., Buldini, B., Pession, A., Locatelli, Franco, Basso, G., Pigazzi, M., and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
The somatic translocation t(8;21)(q22;q22)/RUNX1-RUNX1T1 is one of the most frequent rearrangements found in children with standard-risk acute myeloid leukemia (AML). Despite the favorable prognostic role of this aberration, we recently observed a higher than expected frequency of relapse. Here, we employed an integrated high-throughput approach aimed at identifying new biological features predicting relapse among 34 t(8;21)-rearranged patients. We found that the DNA methylation status of patients who suffered from relapse was peculiarly different from that of children maintaining complete remission. The epigenetic signature, made up of 337 differentially methylated regions, was then integrated with gene and protein expression profiles, leading to a network, where cell-to-cell adhesion and cell-motility pathways were found to be aberrantly activated in relapsed patients. We identified most of these factors as RUNX1-RUNX1T1 targets, with Ras Homolog Family Member (RHOB) overexpression being the core of this network. We documented how RHOB re-organized the actin cytoskeleton through its downstream ROCK-LIMK-COFILIN axis: this increases blast adhesion by stress fiber formation, and reduces mitochondrial apoptotic cell death after chemotherapy treatment. Altogether, our data show an epigenetic heterogeneity within t(8;21)-rearranged AML patients at diagnosis able to influence the program of the chimeric transcript, promoting blast re-emergence and progression to relapse.
- Published
- 2018
23. Multiplicative representations of surface groups
- Author
-
Manara, E, KUHN, MARIA GABRIELLA, MANARA, ELIA, Manara, E, KUHN, MARIA GABRIELLA, and MANARA, ELIA
- Abstract
Un gruppo di superficie è (isomorfo) al gruppo fondamentale di una superficie orientabile chiusa di genere k (maggiore o uguale a 2). È uno small cancellation group e quindi iperbolico; il suo grafo di Cayley è isomorfo a una tassellatura del piano iperbolico fatta di 2k-goni iperbolici. È possibile definire alcuni sottoinsiemi del grafo di Cayley, detti “coni”, su cui il gruppo agisce con un numero finito di orbite, chiamate “cono tipi”. Una rappresentazione moltiplicativa di un gruppo di superficie è una rappresentazione unitaria definita sullo spazio di Hilbert delle funzioni moltiplicative. Una funzione moltiplicativa su un gruppo di superfici ha valori vettoriali ed è definita mediante la scelta di un insieme di parametri, chiamato “sistema di matrici”. Due funzioni moltiplicative sono equivalenti se differiscono solo su un numero finito di elementi. Si può definire un prodotto interno sulle classi di equivalenza di funzioni moltiplicative. Dimostriamo che almeno per il caso di un gruppo di superficie del genere 2 ed una scelta del sistemi di matrici il prodotto interno non è identicamente nullo; dato che esso non dipende dalla scelta dei rappresentanti per le funzioni moltiplicative, è ben definito. Questa dimostrazione si basa sull'irriducibilità di una certa matrice associata alla geometria del grafo di Cayley; in particolare, un certo autovalore Perron-Frobenius deve essere semplice. Una rappresentazione moltiplicativa agisce semplicemente per traslazione sinistra sul completamento dello spazio di Hilbert dello spazio delle funzioni moltiplicative rispetto al prodotto interno sopra menzionato. La rappresentazione così definita è temperata: mostriamo che i coefficienti di matrice della rappresentazione regolare approssimano quelli della rappresentazione moltiplicativa. Con il termine “rappresentazione sul bordo” intendiamo una rappresentazione di una certa C*-algebra prodotto incrociato, ottenuta dall'azione del gruppo di superficie sulla C*-alge, A surface group is (isomorphic to) the fundamental group of a closed orientable surface of genus k greater or equal than 2. It is a small cancellation group (hence hyperbolic); its Cayley graph is isomorphic to a tiling of the hyperbolic plane by 2k-gons. One can define certain subsets of the Cayley graph called cones. The group acts on the set of cones with finitely many orbits, called cone types. A multiplicative representation of a surface group is a unitary representation defined on the Hilbert space of multiplicative functions. A multiplicative function on a surface group is a vector-valued function defined through the choice of a set of parameters, called matrix system. Two multiplicative functions are equivalent if they differ only on finitely many elements. An inner product can be defined for equivalence classes of multiplicative functions. We prove that at least for the case of a surface group of genus 2 and a choice of the matrices as non-negative scalars the inner product is not identically zero; thus, since it does not depend on the representatives for the multiplicative functions, it is well posed. This proof relies on the irreducibility of a certain matrix associated with the geometry of the Cayley graph; in particular, a certain Perron-Frobenius eigenvalue must be simple. A multiplicative representation then simply acts by left translation on the Hilbert space completion of the space of multiplicative functions with respect to the inner product above mentioned. The representation thus defined is tempered: we show that the matrix coefficients of the regular representation approximate those of the multiplicative representation. By the term boundary representation, we mean a representation of a certain crossed product C*-algebra, obtained by the action of the surface group on the C*-algebra of continuous functions on its boundary – which is homeomorphic to the unit circle. Such a boundary representation is given by a unitary representation of the group a
- Published
- 2018
24. Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing
- Author
-
Togni, M, Masetti, R, Pigazzi, M, Astolfi, A, Zama, D, Indio, V, Serravalle, S, Manara, E, Bisio, V, Rizzari, C, Basso, G, Pession, A, Locatelli, F, Togni M., Masetti R., Pigazzi M., Astolfi A., Zama D., Indio V., Serravalle S., Manara E., Bisio V., Rizzari C., Basso G., Pession A., Locatelli F., Togni, M, Masetti, R, Pigazzi, M, Astolfi, A, Zama, D, Indio, V, Serravalle, S, Manara, E, Bisio, V, Rizzari, C, Basso, G, Pession, A, Locatelli, F, Togni M., Masetti R., Pigazzi M., Astolfi A., Zama D., Indio V., Serravalle S., Manara E., Bisio V., Rizzari C., Basso G., Pession A., and Locatelli F.
- Abstract
The genomic landscape of children with acute myeloid leukemia (AML) who do not carry any cytogenetic abnormality (CN-AML) is particularly heterogeneous and challenging, being characterized by different clinical outcomes. To provide new genetic insights into this AML subset, we analyzed through RNA-seq 13 pediatric CN-AML cases, corroborating our findings in an independent cohort of 168 AML patients enrolled in the AIEOP AML 2002/01 study. We identified a chimeric transcript involving NUP98 and PHF23, resulting from a cryptic t(11;17)(p15;p13) translocation, demonstrating, for the first time, that NUP98-PHF23 is a novel recurrent (2.6 %) abnormality in pediatric CN-AML.
- Published
- 2015
25. Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement
- Author
-
Pigazzi, M, Manara, E, Buldini, B, Beqiri, V, Bisio, V, Tregnago, C, Rondelli, R, Masetti, R, Caterina Putti, M, Fagioli, F, Rizzari, C, Pession, A, Locatelli, F, Basso, G, Pigazzi M., Manara E., Buldini B., Beqiri V., Bisio V., Tregnago C., Rondelli R., Masetti R., Caterina Putti M., Fagioli F., Rizzari C., Pession A., Locatelli F., Basso G., Pigazzi, M, Manara, E, Buldini, B, Beqiri, V, Bisio, V, Tregnago, C, Rondelli, R, Masetti, R, Caterina Putti, M, Fagioli, F, Rizzari, C, Pession, A, Locatelli, F, Basso, G, Pigazzi M., Manara E., Buldini B., Beqiri V., Bisio V., Tregnago C., Rondelli R., Masetti R., Caterina Putti M., Fagioli F., Rizzari C., Pession A., Locatelli F., and Basso G.
- Published
- 2015
26. Naturally-occurring and cultured bacteriophages in human therapy.
- Author
-
KIANI, A. K., ANPILOGOV, K., DHULI, K., PAOLACCI, S., BENEDETTI, S., MANARA, E., GUERRI, G., DAUTAJ, A., BECCARI, T., DUNDAR, M., and BERTELLI, M.
- Abstract
OBJECTIVE: The aim of the study was to show the importance of developing techniques that could exploit the potential of bacteriophages as therapeutics or food supplements. MATERIALS AND METHODS: PubMed database was searched using the following combination of keywords: (bacteriophage) AND (human therapy); (natural bacteriophage) AND (application). RESULTS: The increasing antibiotic resistance of many bacterial strains is making standard antibiotic treatments less effective. Phage therapy provides a non-antibiotic alternative with greater specificity and without harmful effects on the human microbiota. Phages target their specific bacteria, replicate, and then, destroy the host pathogen. Bacteriophages may be administered by several routes, including topical, oral and intravenous. They not only destroy the host pathogen but, in some cases, increase the sensitivity of host bacteria to antibiotics. Various studies have shown that combining phage therapy and antibiotic treatment can be effective against bacterial infections. Clinical trials of phage therapy have shown promising results for various human diseases and conditions. With advances in genetic engineering and molecular techniques, bacteriophages will be able to target a wide range of bacteria. CONCLUSIONS: In the future, phage therapy promises to become an effective therapeutic option for bacterial infections. Since many potentially beneficial bacteriophages can be found in food, supplements containing bacteriophages could be designed to remodel gut microbiota and eliminate pathogenic bacteria. Remodeling of gut microbiota could correct gut dysbiosis. The order of phages known to have these promising activities is Caudovirales, especially the families Siphoviridae and Myoviridae. [ABSTRACT FROM AUTHOR]
- Published
- 2021
27. Study of the effects of Lemna minor extracts on human immune cell populations.
- Author
-
CARDOSO, C. CATELANI, MIRALDI, E., CECCARINI, M. R., NAUREEN, Z., BAINI, G., MANARA, E., ANPILOGOV, K., CAMILLERI, G., DHULI, K., PAOLACCI, S., RIA, F., DI SANTE, G., CAMPONESCHI, C., TREDICINE, M., ZANLARI, A., CHIURAZZI, P., BECCARI, T., and BERTELLI, M.
- Abstract
OBJECTIVE: Lemna minor is a plant with a huge repertoire of secondary metabolites. The literature indicates that extracts of Lemna minor have antioxidant, antiradical, immunomodulatory and anti-inflammatory properties. The objective of the present study was to find a suitable technique to extract active compounds from this plant and verify whether these extracts have immunomodulatory activity. MATERIALS AND METHODS: We grew L. minor on a standard medium with Gamborg B5 and vitamins. We extracted compounds from the plant by maceration and decoction. The phytochemical profile of the extracts was characterized by chromatography, spectrophotometry, and spectroscopy. The extracts were tested on cultures of mononuclear cells from four human subjects. These cells were pulsed with carboxyfluorescein succinimidyl ester, grown in triplicate in standard culture medium without (control) and with increasing concentrations of Lemna extracts. Flow cytometry was used to evaluate cell death and proliferation of the total mononuclear cell population and of CD4+, CD8+, B cell and monocyte populations. RESULTS: The Lemna extracts were not cytotoxic and did not cause cell necrosis or apoptosis in immune cells. At low concentrations, they induced very limited proliferation of CD4+ cells within 48 hours. At high concentrations, they induced proliferation of CD8+ cells and B lymphocytes within 48 hours. CONCLUSIONS: Unfortunately, we failed to confirm any immunomodulatory activity of Lemna extracts. Growth and death rates of human immune cells were not significantly affected by adding Lemna extracts to the culture medium. [ABSTRACT FROM AUTHOR]
- Published
- 2021
28. Steroid-converting enzymes in human adipose tissues and fat deposition with a focus on AKR1C enzymes.
- Author
-
KIANI, A. K., MOR, M., BERNINI, A., FULCHERI, E., MICHELINI, S., HERBST, K. L., BUFFELLI, F., BELGRADO, J.-P., KAFTALLI, J., STUPPIA, L., DAUTAJ, A., DHULI, K., GUDA, T., MANARA, E., MALTESE, P. E., CHIURAZZI, P., PAOLACCI, S., CECCARINI, M. R., BECCARI, T., and BERTELLI, M.
- Abstract
Adipocytes express various enzymes, such as aldo-keto reductases (AKR1C), 11β-hydroxysteroid dehydrogenase (11β-HSD), aromatase, 5α-reductases, 3β-HSD, and 17β-HSDs involved in steroid hormone metabolism in adipose tissues. Increased activity of AKR1C enzymes and their expression in mature adipocytes might indicate the association of these enzymes with subcutaneous adipose tissue deposition. The inactivation of androgens by AKR1C enzymes increases adipogenesis and fat mass, particularly subcutaneous fat. AKR1C also causes reduction of estrone, a weak estrogen, to produce 17β-estradiol, a potent estrogen and, in addition, it plays a role in progesterone metabolism. Functional impairments of adipose tissue and imbalance of steroid biosynthesis could lead to metabolic disturbances. In this review, we will focus on the enzymes involved in steroid metabolism and fat tissue deposition. [ABSTRACT FROM AUTHOR]
- Published
- 2021
29. Genetics of fat deposition.
- Author
-
CAMILLERI, G., KIANI, A. K., HERBST, K. L., KAFTALLI, J., BERNINI, A., DHULI, K., MANARA, E., BONETTI, G., STUPPIA, L., PAOLACCI, S., DAUTAJ, A., and BERTELLI, M.
- Abstract
Adipose tissue distribution usually varies among men and women. In men, adipose tissue is known to accumulate in the abdominal region surrounding the visceral organs (android fat distribution) whereas, in women, the accumulation of adipose tissue generally occurs in the gluteal-femoral regions (gynoid fat distribution). In some cases, however, android distribution can be found in women and gynoid distribution can be found in men. The regulation of adipose tissue accumulation involves interaction of a variety of genetic and environmental factors. This review examines genetic factors that cause differential distribution of adipose tissue in different depots of the body, between men and women and between different ethnicities. Genome-wide association studies can be used to identify genetic associations with the distribution and accumulation of adipose tissue. Insight into adipose tissue accumulation and distribution mechanisms could lead to development of personalized interventions for people who develop increased fat mass. [ABSTRACT FROM AUTHOR]
- Published
- 2021
30. Pheromone receptors and their putative ligands: possible role in humans.
- Author
-
PRECONE, V., PAOLACCI, S., BECCARI, T., RAGIONE, L. DALLA, STUPPIA, L., BAGLIVO, M., GUERRI, G., MANARA, E., TONINI, G., HERBST, K. L., UNFER, V., and BERTELLI, M.
- Abstract
Pheromones are ectohormones that play an important role in communication and behavior. Pheromones and pheromone receptor genes are important in mice and other mammals that rely heavily on pheromone cues to survive. Although there is controversy about whether pheromones and pheromone receptor genes have the same importance or are even active in humans, there are some hints that they might have roles in sociosexual behavior and mental disorders. The aim of this qualitative review was to provide an overview of the state of the art regarding pheromones and pheromone receptors in humans and their possible implications in human physiology and pathology. An electronic search was conducted in MEDLINE, PubMed and Scopus databases for articles published in English up to December 2018. The search concerned a possible role of pheromones and pheromone receptors in humans with implications for sociosexual behavior, mental disorders, the menstrual cycle and nutrition. Pheromone communication in humans has not been definitively demonstrated. However, the potential ability of putative pheromones to activate the hypothalamus, which controls the release of many hormones, suggests they could have a role in systemic functions in humans. Future confirmation of the effects of pheromones and pheromone receptors in humans could be useful in the prevention and treatment of various human disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2020
31. Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group
- Author
-
Manara, E., Basso, G., Zampini, M., Buldini, B., Tregnago, C., Rondelli, R., Masetti, R., Bisio, V., Frison, M., Polato, K., Cazzaniga, G., Menna, G., Fagioli, F., Merli, P., Biondi, A., Pession, A., Locatelli, Franco, Pigazzi, M., Locatelli F. (ORCID:0000-0002-7976-3654), Manara, E., Basso, G., Zampini, M., Buldini, B., Tregnago, C., Rondelli, R., Masetti, R., Bisio, V., Frison, M., Polato, K., Cazzaniga, G., Menna, G., Fagioli, F., Merli, P., Biondi, A., Pession, A., Locatelli, Franco, Pigazzi, M., and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
Recurrent molecular markers have been routinely used in acute myeloid leukemia (AML) for risk assessment at diagnosis, whereas their post-induction monitoring still represents a debated issue. We evaluated the prognostic value and biological impact of minimal residual disease (MRD) and of the allelic ratio (AR) of FLT3-internal-tandem duplication (ITD) in childhood AML. We retrospectively screened 494 children with de novo AML for FLT3-ITD mutation, identifying 54 harboring the mutation; 51% of them presented high ITD-AR at diagnosis and had worse event-free survival (EFS, 19.2 versus 63.5% for low ITD-AR, <0.05). Forty-one percent of children with high levels of MRD after the 1st induction course, measured by a patient-specific real-time-PCR, had worse EFS (22.2 versus 59.4% in low-MRD patients, P<0.05). Next, we correlated these parameters with gene expression, showing that patients with high ITD-AR or persistent MRD had characteristic expression profiles with deregulated genes involved in methylation and acetylation. Moreover, patients with high CyclinA1 expression presented an unfavorable EFS (20.3 versus 51.2% in low CyclinA1 group, P<0.01). Our results suggest that ITD-AR levels and molecular MRD should be considered in planning clinical management of FLT3-ITD patients. Different transcriptional activation of epigenetic and oncogenic profiles may explain variability in outcome among these patients, for whom novel therapeutic approaches are desirable.
- Published
- 2017
32. NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: A report from the AIEOP-AML group
- Author
-
Bisio, V., Zampini, M., Tregnago, C., Manara, E., Salsi, V., Di Meglio, A., Masetti, R., Togni, M., Di Giacomo, D., Minuzzo, S., Leszl, A., Zappavigna, V., Rondelli, R., Mecucci, C., Pession, A., Locatelli, Franco, Basso, G., Pigazzi, M., Locatelli F. (ORCID:0000-0002-7976-3654), Bisio, V., Zampini, M., Tregnago, C., Manara, E., Salsi, V., Di Meglio, A., Masetti, R., Togni, M., Di Giacomo, D., Minuzzo, S., Leszl, A., Zappavigna, V., Rondelli, R., Mecucci, C., Pession, A., Locatelli, Franco, Basso, G., Pigazzi, M., and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
NO ABSCTRACT
- Published
- 2017
33. Clinical and molecular findings in an Albanian family with familial adenomatous polyposis
- Author
-
Maltese, P E, primary, Saverio, G Di, additional, Manara, E, additional, Fanelli, F, additional, Capodicasa, N, additional, Guraj, D, additional, Shehaj, I, additional, Amato, B, additional, Laku, A Babameto, additional, Michelini, S, additional, and Bertelli, M, additional
- Published
- 2017
- Full Text
- View/download PDF
34. Putative role of Brugada syndrome genes in familial atrial fibrillation.
- Author
-
MALTESE, P. E., ALDANOVA, E., KRIUCHKOVA, N., AVERIANOV, A., MANARA, E., PAOLACCI, S., BRUSON, A., MIOTTO, R., SARTORI, M., GUERRI, G., ZUNTINI, M., MARCEDDU, G., TEZZELE, S., TADTAEVA, K., CHERNOVA, A., AKSYUTINA, N., NIKULINA, S., NODARI, S., and BERTELLI, M.
- Abstract
OBJECTIVE: Familial atrial fibrillation (FAF), a not uncommon arrhythmia of the atrium, is characterized by heritability, early onset and absence of other heart defects. The molecular and genetic basis is still not completely clear and genetic diagnosis cannot be achieved in about 90% of patients. In this study, we present the results of genetic screening by next generation sequencing in affected Russian families. PATIENTS AND METHODS: Sixty subjects (18 probands and 42 relatives) with a clinical diagnosis of FAF were enrolled in the study. Since AF frequently associates with other cardiomyopathies, we included all genes that were known to be associated with these disorders at the time of our study. All probands were therefore systematically screened for 47 genes selected from the literature. RESULTS: Our study revealed that seven variants co-segregated with the clinical phenotype in seven families. Interestingly, four out of six genes and three out of seven variants have already been associated with Brugada syndrome in the literature. CONCLUSIONS: To our knowledge, this is the first report of association of the CACNA1C, CTNNA3, PKP2, ANK2 and SCN10A genes with FAF; it is also the first study in Russian families. [ABSTRACT FROM AUTHOR]
- Published
- 2019
35. PipeMAGI: an integrated and validated workflow for analysis of NGS data for clinical diagnostics.
- Author
-
MARCEDDU, G., DALLAVILLA, T., GUERRI, G., MANARA, E., CHIURAZZI, P., and BERTELLI, M.
- Abstract
OBJECTIVE: We describe how to set up a custom workflow for the analysis of next generation sequencing (NGS) data suitable for the diagnosis of genetic disorders and that meets the strictest standards of quality and accuracy. Our method goes from DNA extraction to data analysis with a computational in-house pipeline. The system was extensively validated using three publicly available Coriell samples, estimating accuracy, sensitivity and specificity. Multiple runs were also made to assess repeatability and reproducibility. MATERIALS AND METHODS: Three different Coriell samples were analyzed in a single run to perform coverage, sensitivity, specificity, accuracy, reproducibility and repeatability analysis. The three samples were analyzed with a custom-made oligonucleotide probe library using Nextera Rapid Capture enrichment technique and subsequently quantified using the Qubit method. Sample quality was verified using a 4200 TapeStation and sequenced on a MiSeq personal sequencer. Analysis of NGS data was then performed with a custom pipeline. RESULTS: The workflow enabled an accurate and precise analysis of NGS data that meets all the requirements of quality and accuracy required by international standards such as ISO15189 and the Association of Molecular Pathology. CONCLUSIONS: The proposed analysis/validation workflow has high assay accuracy, precision and robustness and can, therefore, be used for clinical diagnostic applications. [ABSTRACT FROM AUTHOR]
- Published
- 2019
36. NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group
- Author
-
Bisio, V, primary, Zampini, M, additional, Tregnago, C, additional, Manara, E, additional, Salsi, V, additional, Di Meglio, A, additional, Masetti, R, additional, Togni, M, additional, Di Giacomo, D, additional, Minuzzo, S, additional, Leszl, A, additional, Zappavigna, V, additional, Rondelli, R, additional, Mecucci, C, additional, Pession, A, additional, Locatelli, F, additional, Basso, G, additional, and Pigazzi, M, additional
- Published
- 2016
- Full Text
- View/download PDF
37. Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group
- Author
-
Manara, E, primary, Basso, G, additional, Zampini, M, additional, Buldini, B, additional, Tregnago, C, additional, Rondelli, R, additional, Masetti, R, additional, Bisio, V, additional, Frison, M, additional, Polato, K, additional, Cazzaniga, G, additional, Menna, G, additional, Fagioli, F, additional, Merli, P, additional, Biondi, A, additional, Pession, A, additional, Locatelli, F, additional, and Pigazzi, M, additional
- Published
- 2016
- Full Text
- View/download PDF
38. Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement
- Author
-
Pigazzi, M., Manara, E., Buldini, B., Beqiri, V., Bisio, V., Tregnago, C., Rondelli, R., Masetti, R., Caterina Putti, M., Fagioli, F., Rizzari, C., Pession, A., Locatelli, Franco, Basso, G., Locatelli F. (ORCID:0000-0002-7976-3654), Pigazzi, M., Manara, E., Buldini, B., Beqiri, V., Bisio, V., Tregnago, C., Rondelli, R., Masetti, R., Caterina Putti, M., Fagioli, F., Rizzari, C., Pession, A., Locatelli, Franco, Basso, G., and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
no abstract
- Published
- 2015
39. Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing
- Author
-
Togni, M., Masetti, R., Pigazzi, M., Astolfi, A., Zama, D., Indio, V., Serravalle, S., Manara, E., Bisio, V., Rizzari, C., Basso, G., Pession, A., Locatelli, Franco, Locatelli F. (ORCID:0000-0002-7976-3654), Togni, M., Masetti, R., Pigazzi, M., Astolfi, A., Zama, D., Indio, V., Serravalle, S., Manara, E., Bisio, V., Rizzari, C., Basso, G., Pession, A., Locatelli, Franco, and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
The genomic landscape of children with acute myeloid leukemia (AML) who do not carry any cytogenetic abnormality (CN-AML) is particularly heterogeneous and challenging, being characterized by different clinical outcomes. To provide new genetic insights into this AML subset, we analyzed through RNA-seq 13 pediatric CN-AML cases, corroborating our findings in an independent cohort of 168 AML patients enrolled in the AIEOP AML 2002/01 study. We identified a chimeric transcript involving NUP98 and PHF23, resulting from a cryptic t(11;17)(p15;p13) translocation, demonstrating, for the first time, that NUP98-PHF23 is a novel recurrent (2.6 %) abnormality in pediatric CN-AML.
- Published
- 2015
40. Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement
- Author
-
Pigazzi, M., primary, Manara, E., additional, Buldini, B., additional, Beqiri, V., additional, Bisio, V., additional, Tregnago, C., additional, Rondelli, R., additional, Masetti, R., additional, Putti, M. C., additional, Fagioli, F., additional, Rizzari, C., additional, Pession, A., additional, Locatelli, F., additional, and Basso, G., additional
- Published
- 2014
- Full Text
- View/download PDF
41. Characterization of children with FLT3-ITDacute myeloid leukemia: a report from the AIEOP AML-2002 study group
- Author
-
Manara, E, Basso, G, Zampini, M, Buldini, B, Tregnago, C, Rondelli, R, Masetti, R, Bisio, V, Frison, M, Polato, K, Cazzaniga, G, Menna, G, Fagioli, F, Merli, P, Biondi, A, Pession, A, Locatelli, F, and Pigazzi, M
- Abstract
Recurrent molecular markers have been routinely used in acute myeloid leukemia (AML) for risk assessment at diagnosis, whereas their post-induction monitoring still represents a debated issue. We evaluated the prognostic value and biological impact of minimal residual disease (MRD) and of the allelic ratio (AR) of FLT3-internal-tandem duplication (ITD) in childhood AML. We retrospectively screened 494 children with de novoAML for FLT3-ITDmutation, identifying 54 harboring the mutation; 51% of them presented high ITD-AR at diagnosis and had worse event-free survival (EFS, 19.2 versus 63.5% for low ITD-AR, <0.05). Forty-one percent of children with high levels of MRD after the 1st induction course, measured by a patient-specific real-time-PCR, had worse EFS (22.2 versus 59.4% in low-MRD patients, P<0.05). Next, we correlated these parameters with gene expression, showing that patients with high ITD-AR or persistent MRD had characteristic expression profiles with deregulated genes involved in methylation and acetylation. Moreover, patients with high CyclinA1expression presented an unfavorable EFS (20.3 versus 51.2% in low CyclinA1group, P<0.01). Our results suggest that ITD-AR levels and molecular MRD should be considered in planning clinical management of FLT3-ITDpatients. Different transcriptional activation of epigenetic and oncogenic profiles may explain variability in outcome among these patients, for whom novel therapeutic approaches are desirable.
- Published
- 2017
- Full Text
- View/download PDF
42. Reply to the Letter "The development of Brugada syndrome phenotype is multifactorial, combining genetic and environmental factors".
- Author
-
Maltese, P. E., Aldanova, E., Kriuchkova, N., Averianov, A., Manara, E., Paolacci, S., Bruson, A., Miotto, R., Sartori, M., Guerri, G., Zuntini, M., Marceddu, G., Tezzele, S., Tadtaeva, K., Chernova, A., Aksyutina, N., Nikulina, S., Nodari, S., and Bertelli, M.
- Published
- 2020
43. Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group
- Author
-
Martina Pigazzi, Barbara Buldini, Valeria Bisio, Katia Polato, Roberto Rondelli, Andrea Pession, Elena Manara, Pietro Merli, Giuseppe Basso, Franca Fagioli, Claudia Tregnago, M Frison, Matteo Zampini, Giovanni Cazzaniga, Giuseppe Menna, Andrea Biondi, Riccardo Masetti, Francesco Locatelli, Manara, E., Basso, G, Zampini, M., Buldini, B., Tregnago, C., Rondelli, R., Masetti, R., Bisio, V., Frison, M., Polato, K., Cazzaniga, G., Menna, G., Fagioli, F., Merli, P., Biondi, A., Pession, A., Locatelli, F., Pigazzi, M., Manara, E, Zampini, M, Buldini, B, Tregnago, C, Rondelli, E, Masetti, R, Bisio, V, Frison, M, Polato, K, Cazzaniga, G, Menna, G, Fagioli, F, Merli, P, Biondi, A, Pession, A, Locatelli, F, and Pigazzi, M
- Subjects
Oncology ,Myeloid ,Cancer Research ,Neoplasm, Residual ,cyclin a1 ,Epigenesis, Genetic ,0302 clinical medicine ,internal tandem duplication ,histone deacetylase inhibitor ,acute myelogenous leukemia ,minimal residual disease ,induction therapy ,risk group ,aml ,cells ,mutations ,Hematology ,Anesthesiology and Pain Medicine ,AML ,hemic and lymphatic diseases ,Gene duplication ,Child ,Leukemic ,Leukemia ,Gene Expression Regulation, Leukemic ,Myeloid leukemia ,Prognosis ,Leukemia, Myeloid, Acute ,medicine.anatomical_structure ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,030220 oncology & carcinogenesis ,Child, Preschool ,Residual ,medicine.medical_specialty ,Acute ,Disease-Free Survival ,03 medical and health sciences ,Genetic ,Internal medicine ,medicine ,Humans ,Preschool ,Retrospective Studies ,business.industry ,medicine.disease ,Minimal residual disease ,Lymphoma ,body regions ,fms-Like Tyrosine Kinase 3 ,Gene Expression Regulation ,Fms-Like Tyrosine Kinase 3 ,Immunology ,Neoplasm ,business ,030215 immunology ,Epigenesis - Abstract
Recurrent molecular markers have been routinely used in acute myeloid leukemia (AML) for risk assessment at diagnosis, whereas their post-induction monitoring still represents a debated issue. We evaluated the prognostic value and biological impact of minimal residual disease (MRD) and of the allelic ratio (AR) of FLT3-internal-tandem duplication (ITD) in childhood AML. We retrospectively screened 494 children with de novo AML for FLT3-ITD mutation, identifying 54 harboring the mutation; 51% of them presented high ITD-AR at diagnosis and had worse event-free survival (EFS, 19.2 versus 63.5% for low ITD-AR
- Published
- 2017
44. A novel complex genomic rearrangement affecting the KCNJ2 regulatory region causes a variant of Cooks syndrome
- Author
-
Elena Manara, Luigia Cinque, Orazio Palumbo, Matteo Bertelli, Lucia Micale, Simona Bianco, Mario Nicodemi, Marco Castori, Angelantonio Notarangelo, Maria Grazia Giuffrida, Laura Bernardini, Andrea M. Chiariello, Giulia Guerri, Andrea Esposito, Cinque, L., Micale, L., Manara, E., Esposito, A., Palumbo, O., Chiariello, A. M., Bianco, S., Guerri, G., Bertelli, M., Giuffrida, M. G., Bernardini, L., Notarangelo, A., Nicodemi, M., and Castori, M.
- Subjects
Genetics ,Chromosome 17 (human) ,Cardiovascular and Metabolic Diseases ,Regulatory sequence ,Breakpoint ,Locus (genetics) ,Chromosomal translocation ,Biology ,Enhancer ,Gene ,Genetics (clinical) ,Chromatin - Abstract
Cooks syndrome (CS) is an ultrarare limb malformation due to in tandem microduplications involving KCNJ2 and extending to the 5' regulatory element of SOX9. To date, six CS families were resolved at the molecular level. Subsequent studies explored the evolutionary and pathological complexities of the SOX9-KCNJ2/Sox9-Kcnj2 locus, and suggested a key role for the formation of novel topologically associating domain (TAD) by inter-TAD duplications in causing CS. Here, we report a unique case of CS associated with a de novo 1;17 translocation affecting the KCNJ2 locus. On chromosome 17, the breakpoint mapped between KCNJ16 and KCNJ2, and combined with a ~ 5 kb deletion in the 5' of KCNJ2. Based on available capture Hi-C data, the breakpoint on chromosome 17 separated KCNJ2 from a putative enhancer. Gene expression analysis demonstrated downregulation of KCNJ2 in both patient's blood cells and cultured skin fibroblasts. Our findings suggest that a complex rearrangement falling in the 5' of KCNJ2 may mimic the developmental consequences of in tandem duplications affecting the SOX9-KCNJ2/Sox9-Kcnj2 locus. This finding adds weight to the notion of an intricate role of gene regulatory regions and, presumably, the related three-dimensional chromatin structure in normal and abnormal human morphology.
- Published
- 2022
45. Investigation on the role of biallelic variants in VEGF-C found in a patient affected by Milroy-like lymphedema
- Author
-
Sylvain Mukenge, Matteo Bertelli, Andrea Brendolan, Elisa Lenti, Michael Jeltsch, Luca Aldrighetti, Sawan Kumar Jha, Daniela Negrini, Elena Manara, Veli-Matti Leppänen, Marco Catena, CAN-PRO - Translational Cancer Medicine Program, Michael Jeltsch / Principal Investigator, Research Programs Unit, University of Helsinki, Kari Alitalo / Principal Investigator, Helsinki One Health (HOH), INDIVIDRUG - Individualized Drug Therapy, Mukenge, S., Jha, S. K., Catena, M., Manara, E., Leppanen, V. -M., Lenti, E., Negrini, D., Bertelli, M., Brendolan, A., Jeltsch, M., and Aldrighetti, L.
- Subjects
0301 basic medicine ,Proband ,Male ,lymphatic system ,Milroy disease ,mutation ,primary lymphedema ,VEGF-C ,VEGF‐C ,Vascular Endothelial Growth Factor C ,Disease ,030105 genetics & heredity ,medicine.disease_cause ,GROWTH FACTOR-C ,Lymphedema ,Child ,Genetics (clinical) ,Genetics ,Mutation ,medicine.diagnostic_test ,1184 Genetics, developmental biology, physiology ,Middle Aged ,Pedigree ,Phenotype ,Original Article ,Female ,LYMPHANGIOGENESIS ,Adult ,lcsh:QH426-470 ,Mutation, Missense ,MECHANISMS ,03 medical and health sciences ,medicine ,Humans ,Primary lymphedema ,Molecular Biology ,Alleles ,Genetic testing ,business.industry ,Original Articles ,medicine.disease ,FLT4 ,lcsh:Genetics ,030104 developmental biology ,Etiology ,3111 Biomedicine ,business - Abstract
Background Milroy‐like disease is the diagnostic definition used for patients with phenotypes that resemble classic Milroy disease (MD) but are negative to genetic testing for FLT4. In this study, we aimed at performing a genetic characterization and biochemical analysis of VEGF‐C variations found in a female proband born with congenital edema consistent with Milroy‐like disease. Methods The proband underwent next‐generation sequencing‐based genetic testing for a panel of genes associated with known forms of hereditary lymphedema. Segregation analysis was performed on family members by direct sequencing. In vitro studies were performed to evaluate the role of a novel identified variant. Results Two VEGF‐C variations were found in the proband, a novel p.(Ser65Arg) and a pathogenic c.148‐3_148‐2delCA, of paternal and maternal origin, respectively. Functional characterization of the p.(Ser65Arg) variation in vitro showed alterations in VEGF‐C processing. Conclusions Our findings reveal an interesting case in which biallelic variants in VEGF‐C are found in a patient with Milroy‐like lymphedema. These data expand our understanding of the etiology of congenital Milroy‐like lymphedema., A genetic and biochemical analysis of VEGF‐C variations were performed on a female proband affected by primary lymphedema of the right lower limb and on her entire family. Biallelic variants of VEGF‐C variations were found in the proband: a novel p.(Ser65Arg) and a pathogenic c.148‐3_148‐2del, of paternal and maternal origin, respectively. Clinical examination of the family by lymphoscintigraphy as well as biochemical analysis show that both variants are required to the development of the proband Milroy‐like lymphedema.
- Published
- 2020
46. Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema
- Author
-
Paolo Enrico Maltese, Astrit Dautaj, Karen L. Herbst, Pietro Chiurazzi, Valerio Marino, Sandro Michelini, Michele Pinelli, Matteo Bertelli, Elena Manara, Daniele Dell'Orco, Mirko Baglivo, Alessandro Fiorentino, Michelini, S., Chiurazzi, P., Marino, V., Dell'Orco, D., Manara, E., Baglivo, M., Fiorentino, A., Maltese, P. E., Pinelli, M., Herbst, K. L., Dautaj, A., and Bertelli, M.
- Subjects
Models, Molecular ,Candidate gene ,subcutaneous fat ,AKR1C1 ,Protein Conformation ,Reductase ,whole exome sequencing ,lcsh:Chemistry ,Loss of Function Mutation ,Medicine ,Missense mutation ,lcsh:QH301-705.5 ,Spectroscopy ,Exome sequencing ,Progesterone ,General Medicine ,Middle Aged ,Computer Science Applications ,molecular modelling ,20-alpha-Dihydroprogesterone ,Pedigree ,Female ,Human ,Adult ,medicine.medical_specialty ,Mutation, Missense ,Molecular Dynamics Simulation ,Catalysis ,Article ,Inorganic Chemistry ,Internal medicine ,Exome Sequencing ,Humans ,aldo-keto reductase activity ,Physical and Theoretical Chemistry ,Molecular Biology ,20-Hydroxysteroid Dehydrogenases ,Aged ,Aldo-keto reductase ,business.industry ,Organic Chemistry ,steroid hormone metabolism ,lipedema ,Endocrinology ,lcsh:Biology (General) ,lcsh:QD1-999 ,Hydroxyprogesterone ,20-Hydroxysteroid Dehydrogenase ,business ,Steroid hormone metabolism - Abstract
Lipedema is an often underdiagnosed chronic disorder that affects subcutaneous adipose tissue almost exclusively in women, which leads to disproportionate fat accumulation in the lower and upper body extremities. Common comorbidities include anxiety, depression, and pain. The correlation between mood disorder and subcutaneous fat deposition suggests the involvement of steroids metabolism and neurohormones signaling, however no clear association has been established so far. In this study, we report on a family with three patients affected by sex-limited autosomal dominant nonsyndromic lipedema. They had been screened by whole exome sequencing (WES) which led to the discovery of a missense variant p.(Leu213Gln) in AKR1C1, the gene encoding for an aldo-keto reductase catalyzing the reduction of progesterone to its inactive form, 20-&alpha, hydroxyprogesterone. Comparative molecular dynamics simulations of the wild-type vs. variant enzyme, corroborated by a thorough structural and functional bioinformatic analysis, suggest a partial loss-of-function of the variant. This would result in a slower and less efficient reduction of progesterone to hydroxyprogesterone and an increased subcutaneous fat deposition in variant carriers. Overall, our results suggest that AKR1C1 is the first candidate gene associated with nonsyndromic lipedema.
- Published
- 2020
47. Vascular anomalies: Molecular bases, genetic testing and therapeutic approaches
- Author
-
Raul Mattassi, Elena Manara, Alice Bruson, Byung-Boong Lee, Sandro Michelini, Stefano Paolacci, Alessandra Zulian, Matteo Bertelli, Bruno Amato, Paolacci, S., Zulian, A., Bruson, A., Manara, E., Michelini, S., Mattassi, R. E., Lee, B. -B., Amato, B., and Bertelli, M.
- Subjects
Genetic Markers ,Vascular Malformations ,Genetic Association Studie ,030204 cardiovascular system & hematology ,030230 surgery ,Bioinformatics ,DNA sequencing ,03 medical and health sciences ,Germ-line mutation ,0302 clinical medicine ,Targeted ngs ,Genetic Marker ,Humans ,Medicine ,Genetic Predisposition to Disease ,Genetic Testing ,Genetic Association Studies ,Genetic testing ,Pharmacology ,Vascular Malformation ,medicine.diagnostic_test ,business.industry ,Mechanism (biology) ,Genetic heterogeneity ,Genetic Variation ,High-Throughput Nucleotide Sequencing ,Vascular Tumors ,Etiology ,Therapy ,Cardiology and Cardiovascular Medicine ,business ,Genetic diagnosis ,Human - Abstract
INTRODUCTION Vascular anomalies encompass an extremely heterogeneous group of congenital abnormalities of the vascular system. They include vascular tumors and malformations and have a prevalence of 4.5%. Vascular anomalies are frequently sporadic and associated with somatic mutations and/or a double-hit mechanism and are characterized by considerable phenotypic and genetic heterogeneity. The aim of this review was to provide a genetic description of vascular anomalies, the sequencing technologies used for their diagnosis and the drugs that may potentially be used for their treatment. EVIDENCE ACQUISITION PubMed, OMIM, Orphanet, Genetic Testing Registry and ClinicalTrials.gov were searched for monogenic vascular anomalies in order to evaluate the genetic tests (based on sequencing) currently used for their diagnosis, and for any drugs that could be useful to treat them. EVIDENCE SYNTHESIS From the search of the clinical synopsis section of OMIM and PubMed for vascular anomalies we selected 19 disorders with a known molecular etiology. From the search for pharmacological trials and therapies in the ClinicalTrials.gov and PubMed databases we selected 87 drugs. CONCLUSIONS Most genetic tests with validated clinical utility are based on a next generation sequencing (NGS) approach. Targeted NGS is indeed the best approach for the analysis of disorders with complex phenotypes and genetics and involvement of somatic mutations. Genetic diagnosis provides data for determine genotype-phenotype correlations, segregation and recurrence risk in families, and new targets for gene- or mutation-specific pharmacological therapies. Improvement of diagnostic techniques is needed to offer patients appropriate care, more focused follow-up, and hopefully drugs to treat their disorders.
- Published
- 2019
48. Segregation Analysis of Rare NRP1 and NRP2 Variants in Families with Lymphedema
- Author
-
Maurizio Ricci, Matteo Bertelli, Dominika Veselenyiova, Sercan Kenanoglu, Munis Dundar, Elena Manara, Lucilla Gagliardi, Giuseppina Matera, Astrit Dautaj, Giacinto Abele Donato Miggiano, Barbara Aquilanti, Sasi Priya, Valeria Velluti, Juraj Krajcovic, Mirko Baglivo, Bruno Amato, Roberta Serrani, Sandro Michelini, Danjela Kurti, Syed Hussain Basha, Michelini, S., Amato, B., Ricci, M., Kenanoglu, S., Veselenyiova, D., Kurti, D., Baglivo, M., Manara, E., Dundar, M., Krajcovic, J., Basha, S. H., Priya, S., Serrani, R., Miggiano, G. A. D., Aquilanti, B., Matera, G., Velluti, V., Gagliardi, L., Dautaj, A., and Bertelli, M.
- Subjects
0301 basic medicine ,Proband ,Genetic diagnostic ,Candidate gene ,Cell signaling ,lcsh:QH426-470 ,Neuropilins ,Bioinformatics ,03 medical and health sciences ,0302 clinical medicine ,hemic and lymphatic diseases ,Neuropilin 1 ,Genetics ,medicine ,NRP1 ,NRP2 ,genetic diagnostics ,Gene ,Genetics (clinical) ,business.industry ,lymphedema ,medicine.disease ,humanities ,body regions ,lcsh:Genetics ,030104 developmental biology ,Lymphedema ,Lymphatic system ,NGS ,030220 oncology & carcinogenesis ,business - Abstract
Neuropilins are transmembrane coreceptors expressed by endothelial cells and neurons. NRP1 and NRP2 bind a variety of ligands, by which they trigger cell signaling, and are important in the development of lymphatic valves and lymphatic capillaries, respectively. This study focuses on identifying rare variants in the NRP1 and NRP2 genes that could be linked to the development of lymphatic malformations in patients diagnosed with lymphedema. Two hundred and thirty-five Italian lymphedema patients, who tested negative for variants in known lymphedema genes, were screened for variants in NRP1 and NRP2. Two probands carried variants in NRP1 and four in NRP2. The variants of both genes segregated with lymphedema in familial cases. Although further functional and biochemical studies are needed to clarify their involvement with lymphedema and to associate NRP1 and NRP2 with lymphedema, we suggest that it is worthwhile also screening lymphedema patients for these two new candidate genes.
- Published
- 2020
49. Multiplicative representations of surface groups
- Author
-
MANARA, ELIA, Manara, E, and KUHN, MARIA GABRIELLA
- Subjects
tempered ,group ,surface ,representation ,MAT/05 - ANALISI MATEMATICA ,C*-algebra - Abstract
Un gruppo di superficie è (isomorfo) al gruppo fondamentale di una superficie orientabile chiusa di genere k (maggiore o uguale a 2). È uno small cancellation group e quindi iperbolico; il suo grafo di Cayley è isomorfo a una tassellatura del piano iperbolico fatta di 2k-goni iperbolici. È possibile definire alcuni sottoinsiemi del grafo di Cayley, detti “coni”, su cui il gruppo agisce con un numero finito di orbite, chiamate “cono tipi”. Una rappresentazione moltiplicativa di un gruppo di superficie è una rappresentazione unitaria definita sullo spazio di Hilbert delle funzioni moltiplicative. Una funzione moltiplicativa su un gruppo di superfici ha valori vettoriali ed è definita mediante la scelta di un insieme di parametri, chiamato “sistema di matrici”. Due funzioni moltiplicative sono equivalenti se differiscono solo su un numero finito di elementi. Si può definire un prodotto interno sulle classi di equivalenza di funzioni moltiplicative. Dimostriamo che almeno per il caso di un gruppo di superficie del genere 2 ed una scelta del sistemi di matrici il prodotto interno non è identicamente nullo; dato che esso non dipende dalla scelta dei rappresentanti per le funzioni moltiplicative, è ben definito. Questa dimostrazione si basa sull'irriducibilità di una certa matrice associata alla geometria del grafo di Cayley; in particolare, un certo autovalore Perron-Frobenius deve essere semplice. Una rappresentazione moltiplicativa agisce semplicemente per traslazione sinistra sul completamento dello spazio di Hilbert dello spazio delle funzioni moltiplicative rispetto al prodotto interno sopra menzionato. La rappresentazione così definita è temperata: mostriamo che i coefficienti di matrice della rappresentazione regolare approssimano quelli della rappresentazione moltiplicativa. Con il termine “rappresentazione sul bordo” intendiamo una rappresentazione di una certa C*-algebra prodotto incrociato, ottenuta dall'azione del gruppo di superficie sulla C*-algebra delle funzioni continue sul bordo - che è omeomorfo ad una circonferenza. Una rappresentazione sul bordo è data da una rappresentazione unitaria del gruppo e una rappresentazione della C*-algebra che soddisfi una condizione di covarianza. Definiamo una famiglia di sottospazi (indicizzata da una quantità reale) di uno spazio di funzioni di quadrato integrabile con valori vettoriali sul gruppo e agiamo su questi sottospazi per traslazione a sinistra con il gruppo e per moltiplicazione con le funzioni continue sulla compattificazione del gruppo di superficie (il gruppo unito al suo bordo). Otteniamo alcune rappresentazioni del gruppo e dell'algebra che soddisfano la covarianza e mostriamo che la famiglia ha una sottosuccessione convergente. Mostriamo quindi che l'azione della C*-algebra coinvolge solo i valori delle funzioni sul bordo: otteniamo quindi una rappresentazione sul bordo. Mostriamo, inoltre, che il limite così ottenuto non dipende dalla sottosuccessione tendente a zero. Abbiamo così una rappresentazione sul bordo ben definita. Mostriamo che la parte unitaria di questa rappresentazione sul bordo è equivalente alla rappresentazione moltiplicativa: infatti, le loro funzioni di tipo positivo coincidono. Infine, mostriamo che la rappresentazione sul bordo è irriducibile. Questo risultato si ottiene sfruttando l'unicità (a meno di prodotto per una costante positiva) dell'autovalore di Perron-Frobenius ottenuto nella dimostrazione della buona positura del prodotto interno: dimostriamo che qualsiasi proiezione che commuta sia con la rappresentazione del gruppo che con la rappresentazione dell’algebra permette di definire un autovettore della stessa matrice corrispondente all'autovalore di Perron-Frobenius. Quindi, dopo alcuni calcoli, otteniamo che la proiezione considerata deve essere banale. Da una versione del Lemma di Schur segue che la rappresentazione del prodotto incrociato è irriducibile. A surface group is (isomorphic to) the fundamental group of a closed orientable surface of genus k greater or equal than 2. It is a small cancellation group (hence hyperbolic); its Cayley graph is isomorphic to a tiling of the hyperbolic plane by 2k-gons. One can define certain subsets of the Cayley graph called cones. The group acts on the set of cones with finitely many orbits, called cone types. A multiplicative representation of a surface group is a unitary representation defined on the Hilbert space of multiplicative functions. A multiplicative function on a surface group is a vector-valued function defined through the choice of a set of parameters, called matrix system. Two multiplicative functions are equivalent if they differ only on finitely many elements. An inner product can be defined for equivalence classes of multiplicative functions. We prove that at least for the case of a surface group of genus 2 and a choice of the matrices as non-negative scalars the inner product is not identically zero; thus, since it does not depend on the representatives for the multiplicative functions, it is well posed. This proof relies on the irreducibility of a certain matrix associated with the geometry of the Cayley graph; in particular, a certain Perron-Frobenius eigenvalue must be simple. A multiplicative representation then simply acts by left translation on the Hilbert space completion of the space of multiplicative functions with respect to the inner product above mentioned. The representation thus defined is tempered: we show that the matrix coefficients of the regular representation approximate those of the multiplicative representation. By the term boundary representation, we mean a representation of a certain crossed product C*-algebra, obtained by the action of the surface group on the C*-algebra of continuous functions on its boundary – which is homeomorphic to the unit circle. Such a boundary representation is given by a unitary representation of the group and a representation of the C*-algebra satisfying a covariance condition. We define a family of subspaces (indexed by a real quantity) of a space of vector-valued square integrable functions on the group and we act on these subspaces by left translation with the group and by multiplication with continuous functions on the compactification of the surface group (the group united with its boundary). Thus, we get some representations of the group and the algebra satisfying covariance and we show that the family has a limit for a subsequence of the indexes tending to zero. We then show that the action of the C*-algebra involves only the values of the functions on the boundary. Hence, we get a boundary representation. We show, moreover, that the limit thus obtained does not depend on the subsequence tending to zero. Hence, we get a well-defined representation of the crossed product C*-algebra. We show that the unitary part of this boundary representation is equivalent to the multiplicative representation: in fact, their functions of positive type coincide. Finally, we show that the boundary representation is irreducible. This result is achieved by exploiting the uniqueness (up to scaling) of the Perron-Frobenius eigenvalue obtained in the proof of the well-posedness of the inner product: in fact, we show that any projection intertwining both the group representation and the algebra representation allows to define an eigenvector of the same matrix corresponding to the Perron-Frobenius eigenvalue. Thus, after some calculations, we get that the projection considered must be trivial. By a version of Schur’s Lemma, this yields the irreducibility of the crossed product representation.
- Published
- 2018
50. Clinical and molecular findings in an Albanian family with familial adenomatous polyposis
- Author
-
P E Maltese, G Di Saverio, E Manara, F Fanelli, N Capodicasa, D Guraj, I Shehaj, B Amato, A Babameto Laku, S Michelini, M Bertelli, Maltese, P. E., Di Saverio, G., Manara, E., Fanelli, F., Capodicasa, N., Guraj, D., Shehaj, I., Amato, B., Babameto-Laku, A., Michelini, S., and Bertelli, M.
- Subjects
Familial adenomatous polyposi ,Genetics ,FAP ,General Medicine ,Colorectal cancer ,Molecular Biology ,APC - Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.